161 related articles for article (PubMed ID: 25622988)
1. Guide for medical professionals (i.e., dermatologists) for the management of Rhododenol-induced leukoderma.
Nishigori C; Aoyama Y; Ito A; Suzuki K; Suzuki T; Tanemura A; Ito M; Katayama I; Oiso N; Kagohashi Y; Sugiura S; Fukai K; Funasaka Y; Yamashita T; Matsunaga K
J Dermatol; 2015 Feb; 42(2):113-28. PubMed ID: 25622988
[TBL] [Abstract][Full Text] [Related]
2. Retention of pigment stem cells in Rhododenol-induced leukoderma: Pathological investigation of 11 patients.
Watanabe S; Yagami A; Iwata Y; Nagai A; Kuroda M; Sugiura K; Matsunaga K
J Dermatol; 2017 Jul; 44(7):e148-e149. PubMed ID: 28516676
[No Abstract] [Full Text] [Related]
3. An immune pathological and ultrastructural skin analysis for rhododenol-induced leukoderma patients.
Tanemura A; Yang L; Yang F; Nagata Y; Wataya-Kaneda M; Fukai K; Tsuruta D; Ohe R; Yamakawa M; Suzuki T; Katayama I
J Dermatol Sci; 2015 Mar; 77(3):185-8. PubMed ID: 25676426
[TBL] [Abstract][Full Text] [Related]
4. Rhododenol-induced leukoderma in a mouse model mimicking Japanese skin.
Abe Y; Okamura K; Kawaguchi M; Hozumi Y; Aoki H; Kunisada T; Ito S; Wakamatsu K; Matsunaga K; Suzuki T
J Dermatol Sci; 2016 Jan; 81(1):35-43. PubMed ID: 26547111
[TBL] [Abstract][Full Text] [Related]
5. A unique system that can sensitively assess the risk of chemical leukoderma by using murine tail skin.
Iida M; Tazaki A; Deng Y; Chen W; Yajima I; Kondo-Ida L; Hashimoto K; Ohgami N; Kato M
Chemosphere; 2019 Nov; 235():713-718. PubMed ID: 31279121
[TBL] [Abstract][Full Text] [Related]
6. Open-label pilot study to evaluate the effectiveness of topical bimatoprost on rhododendrol-induced refractory leukoderma.
Fukaya S; Kamata M; Kasanuki T; Yokobori M; Takeoka S; Hayashi K; Tanaka T; Fukuyasu A; Ishikawa T; Ohnishi T; Iimuro S; Tada Y; Watanabe S
J Dermatol; 2018 Nov; 45(11):1283-1288. PubMed ID: 30156328
[TBL] [Abstract][Full Text] [Related]
7. Immunohistopathological analysis of frizzled-4-positive immature melanocytes from hair follicles of patients with Rhododenol-induced leukoderma.
Okamura K; Ohe R; Abe Y; Ueki M; Hozumi Y; Tamiya G; Matsunaga K; Yamakawa M; Suzuki T
J Dermatol Sci; 2015 Nov; 80(2):156-8. PubMed ID: 26277630
[No Abstract] [Full Text] [Related]
8. Biochemical, cytological, and immunological mechanisms of rhododendrol-induced leukoderma.
Tokura Y; Fujiyama T; Ikeya S; Tatsuno K; Aoshima M; Kasuya A; Ito T
J Dermatol Sci; 2015 Mar; 77(3):146-9. PubMed ID: 25726326
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of CCR4+ CD8+ T cells and elevated plasma CCL22 and CCL17 in patients with rhododenol-induced leukoderma.
Nishioka M; Tanemura A; Yang L; Tanaka A; Arase N; Katayama I
J Dermatol Sci; 2015 Mar; 77(3):188-90. PubMed ID: 25766765
[No Abstract] [Full Text] [Related]
10. Leukoderma induced by rhododendrol is different from leukoderma of vitiligo in pathogenesis: A novel comparative morphological study.
Tsutsumi R; Sugita K; Abe Y; Hozumi Y; Suzuki T; Yamada N; Yoshida Y; Yamamoto O
J Cutan Pathol; 2019 Feb; 46(2):123-129. PubMed ID: 30456919
[TBL] [Abstract][Full Text] [Related]
11. Rhododendrol-induced leukoderma accompanied by allergic contact dermatitis caused by a non-rhododendrol skin-lightening agent, 5,5'-dipropylbiphenyl-2,2'-diol.
Yagami A; Suzuki K; Sano A; Takahashi M; Kobayashi T; Morita Y; Ando A; Iwata Y; Matsunaga K
J Dermatol; 2015 Jul; 42(7):739-40. PubMed ID: 25875673
[No Abstract] [Full Text] [Related]
12. Rhododendrol-induced leukoderma update I: Clinical findings and treatment.
Matsunaga K; Suzuki K; Ito A; Tanemura A; Abe Y; Suzuki T; Yoshikawa M; Sumikawa Y; Yagami A; Masui Y; Inoue S; Ito S; Katayama I
J Dermatol; 2021 Jul; 48(7):961-968. PubMed ID: 33686651
[TBL] [Abstract][Full Text] [Related]
13. Long-term Use of Topical Bimatoprost on Rhododendrol-induced Refractory Leukoderma: A Case Report.
Fukaya S; Kamata M; Kasanuki T; Yokobori M; Takeoka S; Hayashi K; Tanaka T; Fukuyasu A; Ishikawa T; Ohnishi T; Iimuro S; Watanabe S; Tada Y
Acta Derm Venereol; 2019 Nov; 99(12):1178-1179. PubMed ID: 31449314
[No Abstract] [Full Text] [Related]
14. Rhododendrol, a depigmentation-inducing phenolic compound, exerts melanocyte cytotoxicity via a tyrosinase-dependent mechanism.
Sasaki M; Kondo M; Sato K; Umeda M; Kawabata K; Takahashi Y; Suzuki T; Matsunaga K; Inoue S
Pigment Cell Melanoma Res; 2014 Sep; 27(5):754-63. PubMed ID: 24890809
[TBL] [Abstract][Full Text] [Related]
15. Melanocyte-specific cytotoxic T lymphocytes in patients with rhododendrol-induced leukoderma.
Fujiyama T; Ikeya S; Ito T; Tatsuno K; Aoshima M; Kasuya A; Sakabe J; Suzuki T; Tokura Y
J Dermatol Sci; 2015 Mar; 77(3):190-2. PubMed ID: 25724360
[No Abstract] [Full Text] [Related]
16. Clinical and epidemiological analysis in 149 cases of rhododendrol-induced leukoderma.
Yoshikawa M; Sumikawa Y; Hida T; Kamiya T; Kase K; Ishii-Osai Y; Kato J; Kan Y; Kamiya S; Sato Y; Yamashita T
J Dermatol; 2017 May; 44(5):582-587. PubMed ID: 27882588
[TBL] [Abstract][Full Text] [Related]
17. Biochemical Mechanism of Rhododendrol-Induced Leukoderma.
Ito S; Wakamatsu K
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439519
[No Abstract] [Full Text] [Related]
18. Autoantibodies detected in patients with vitiligo vulgaris but not in those with rhododendrol-induced leukoderma.
Arase N; Tanemura A; Jin H; Nishioka M; Aoyama Y; Oiso N; Matsunaga K; Suzuki T; Nishigori C; Kawamura T; Shimizu T; Ito A; Fukai K; Abe Y; Yang L; Tsuruta D; Takeoka K; Iwatani Y; Hidaka Y; Nishida M; Yamauchi-Takihara K; Arase H; Fujimoto M; Katayama I
J Dermatol Sci; 2019 Aug; 95(2):80-83. PubMed ID: 31399283
[No Abstract] [Full Text] [Related]
19. [Leukoderma caused by chemicals: mechanisms underlying 4-alkyl/aryl-substituted phenols- and rhododendrol-induced melanocyte loss].
Nishimaki-Mogami T
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2015; (133):13-20. PubMed ID: 26821466
[TBL] [Abstract][Full Text] [Related]
20. Glutathione maintenance is crucial for survival of melanocytes after exposure to rhododendrol.
Kondo M; Kawabata K; Sato K; Yamaguchi S; Hachiya A; Takahashi Y; Inoue S
Pigment Cell Melanoma Res; 2016 Sep; 29(5):541-9. PubMed ID: 27223685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
